The fight against sudden cardiac death

Consensus guidelines as a reference

Tom Rossenbacker, Silvia G. Priori, Douglas P. Zipes

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Large clinical trial evidence favours the use of implantable cardioverter defibrillators (ICDs) in primary and secondary prevention of sudden cardiac death (SCD). In response, major cardiology organizations have developed practice guidelines to guide clinicians through their decision-making. Although agreement exists on the use of ICDs in cardiac arrest survivors (i.e. secondary prevention), more discussion has been generated by the recommendations for the use of ICDs in primary prevention of SCD. The dramatic differences in enrolment criteria among the primary prevention trials have created debates amongst experts when it comes to defining the use of ICDs in primary prevention: robust recommendations with a firm level of evidence could be formulated for some patient groups but guidelines remain underpowered for other populations. In the future, more studies are needed to strengthen guidelines for patients with well-characterized risk profiles. Second, a robust assessment of device performance in unselected patient populations is also required. Third, an even closer collaboration between clinicians and industry is justified in order to address the technological challenges posed by the continuous expansion of indications for ICDs.

Original languageEnglish
JournalEuropean Heart Journal, Supplement
Volume9
Issue numberI
DOIs
StatePublished - 2007

Fingerprint

Implantable Defibrillators
Sudden Cardiac Death
Primary Prevention
Consensus
Guidelines
Secondary Prevention
Heart Arrest
Cardiology
Practice Guidelines
Population
Survivors
Decision Making
Industry
Clinical Trials
Equipment and Supplies

Keywords

  • Implantable cardioverter defibrillator
  • Practice guidelines
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The fight against sudden cardiac death : Consensus guidelines as a reference. / Rossenbacker, Tom; Priori, Silvia G.; Zipes, Douglas P.

In: European Heart Journal, Supplement, Vol. 9, No. I, 2007.

Research output: Contribution to journalArticle

Rossenbacker, Tom ; Priori, Silvia G. ; Zipes, Douglas P. / The fight against sudden cardiac death : Consensus guidelines as a reference. In: European Heart Journal, Supplement. 2007 ; Vol. 9, No. I.
@article{56bbebfee3614809ab35325b90763706,
title = "The fight against sudden cardiac death: Consensus guidelines as a reference",
abstract = "Large clinical trial evidence favours the use of implantable cardioverter defibrillators (ICDs) in primary and secondary prevention of sudden cardiac death (SCD). In response, major cardiology organizations have developed practice guidelines to guide clinicians through their decision-making. Although agreement exists on the use of ICDs in cardiac arrest survivors (i.e. secondary prevention), more discussion has been generated by the recommendations for the use of ICDs in primary prevention of SCD. The dramatic differences in enrolment criteria among the primary prevention trials have created debates amongst experts when it comes to defining the use of ICDs in primary prevention: robust recommendations with a firm level of evidence could be formulated for some patient groups but guidelines remain underpowered for other populations. In the future, more studies are needed to strengthen guidelines for patients with well-characterized risk profiles. Second, a robust assessment of device performance in unselected patient populations is also required. Third, an even closer collaboration between clinicians and industry is justified in order to address the technological challenges posed by the continuous expansion of indications for ICDs.",
keywords = "Implantable cardioverter defibrillator, Practice guidelines, Sudden cardiac death",
author = "Tom Rossenbacker and Priori, {Silvia G.} and Zipes, {Douglas P.}",
year = "2007",
doi = "10.1093/eurheartj/sum077",
language = "English",
volume = "9",
journal = "European Heart Journal, Supplement",
issn = "1520-765X",
publisher = "Oxford University Press",
number = "I",

}

TY - JOUR

T1 - The fight against sudden cardiac death

T2 - Consensus guidelines as a reference

AU - Rossenbacker, Tom

AU - Priori, Silvia G.

AU - Zipes, Douglas P.

PY - 2007

Y1 - 2007

N2 - Large clinical trial evidence favours the use of implantable cardioverter defibrillators (ICDs) in primary and secondary prevention of sudden cardiac death (SCD). In response, major cardiology organizations have developed practice guidelines to guide clinicians through their decision-making. Although agreement exists on the use of ICDs in cardiac arrest survivors (i.e. secondary prevention), more discussion has been generated by the recommendations for the use of ICDs in primary prevention of SCD. The dramatic differences in enrolment criteria among the primary prevention trials have created debates amongst experts when it comes to defining the use of ICDs in primary prevention: robust recommendations with a firm level of evidence could be formulated for some patient groups but guidelines remain underpowered for other populations. In the future, more studies are needed to strengthen guidelines for patients with well-characterized risk profiles. Second, a robust assessment of device performance in unselected patient populations is also required. Third, an even closer collaboration between clinicians and industry is justified in order to address the technological challenges posed by the continuous expansion of indications for ICDs.

AB - Large clinical trial evidence favours the use of implantable cardioverter defibrillators (ICDs) in primary and secondary prevention of sudden cardiac death (SCD). In response, major cardiology organizations have developed practice guidelines to guide clinicians through their decision-making. Although agreement exists on the use of ICDs in cardiac arrest survivors (i.e. secondary prevention), more discussion has been generated by the recommendations for the use of ICDs in primary prevention of SCD. The dramatic differences in enrolment criteria among the primary prevention trials have created debates amongst experts when it comes to defining the use of ICDs in primary prevention: robust recommendations with a firm level of evidence could be formulated for some patient groups but guidelines remain underpowered for other populations. In the future, more studies are needed to strengthen guidelines for patients with well-characterized risk profiles. Second, a robust assessment of device performance in unselected patient populations is also required. Third, an even closer collaboration between clinicians and industry is justified in order to address the technological challenges posed by the continuous expansion of indications for ICDs.

KW - Implantable cardioverter defibrillator

KW - Practice guidelines

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=65449189705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449189705&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/sum077

DO - 10.1093/eurheartj/sum077

M3 - Article

VL - 9

JO - European Heart Journal, Supplement

JF - European Heart Journal, Supplement

SN - 1520-765X

IS - I

ER -